Charles Schwab’s Climb Bio, Inc. Common Stock CLYM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-70,093
| Closed | -$85.5K | – | 3608 |
|
|
2025
Q1 | $85.5K | Hold |
70,093
| – | – | ﹤0.01% | 3367 |
|
|
2024
Q4 | $126K | Hold |
70,093
| – | – | ﹤0.01% | 3380 |
|
|
2024
Q3 | $357K | Buy |
70,093
+52,965
| +309% | +$270K | ﹤0.01% | 3245 |
|
|
2024
Q2 | $122K | Buy |
+17,128
| New | +$122K | ﹤0.01% | 3467 |
|
|
2022
Q2 | – | Sell |
-16,001
| Closed | -$135K | – | 3661 |
|
|
2022
Q1 | $135K | Sell |
16,001
-1,223
| -7% | -$10.3K | ﹤0.01% | 3370 |
|
|
2021
Q4 | $181K | Hold |
17,224
| – | – | ﹤0.01% | 3371 |
|
|
2021
Q3 | $310K | Buy |
+17,224
| New | +$310K | ﹤0.01% | 3261 |
|